Several factors go into selecting a PGx gene panel test including which genes are on the panel, the scope of variants detected, as well as cost, insurance reimbursement, turn-around-time, ease of use of the report, integration of results into the EHR and other factors. In this white paper, we dig into commercially available comprehensive PGx tests and compare and evaluate the clinical validity of the genes analyzed.
Want more on Pharmacogenomics?
Do you find yourself still asking the following questions about pharmacogenomics:
- How can genetic testing can be used to reduce side effects and improve efficacy of prescription medications?
- Which pharmacogenomic test should I order?
- Does insurance cover pharmacogenomic testing?
If you are interested in learning more about pharmacogenomics, check out our online course, Pharmacogenomics in Practice. Join Dr. Jeanette McCarthy, a genome scientist and leading educator in the field of precision medicine, to learn how to implement pharmacogenomic testing in your practice.
Jeanette McCarthy has been a leading educator in the field of precision medicine for over a decade. She’s designed and delivered dozens of online courses and in-person workshops to healthcare providers, consumers, diagnostic companies, health IT companies, investors and others worldwide.
Dr. McCarthy spent the early part of her career as a molecular epidemiologist at Millennium Pharmaceuticals and in academia, and currently holds adjunct faculty positions at Duke University and the University of California - San Francisco (UCSF). She is the co-author of Precision Medicine: A Guide to Genomics in Clinical Practice, and served as editor-in-chief of Genome, the first magazine dedicated to educating consumers about the promise and challenges of genomic medicine.
Dr. McCarthy is the founder of Precision Medicine Advisors, which brings healthcare organizations, health care providers, diagnostic test developers, health IT companies, investors and others up to speed on the availability, value and limitations of genetic tests on the market and in development.